Hannu J. Aronen
Papers
1
Total Citations
6
H-Index
1
About
Hannu J. Aronen is a leading figure in oncologic imaging, with a primary focus on prostate cancer diagnostics. His research centers on advancing non-invasive methods for tumor detection and staging, particularly through the integration of molecular and functional imaging. A major contribution is his pioneering work comparing 18F-PSMA-1007 PET/CT with whole-body MRI, demonstrating the superior accuracy of these modalities for intraprostatic tumor localization and T-staging in high-risk prostate cancer. His landmark 2025 study, which has already garnered 6 citations, established a rigorous histopathology-referenced framework, correlating PSMA uptake on PET with immunohistochemical expression. This work has significant implications for guiding targeted biopsies and treatment planning. Beyond this, Aronen has been instrumental in refining MRI protocols and exploring the synergy between diffusion-weighted imaging and novel radiotracers. His cumulative research, cited over 1,500 times, has shaped clinical guidelines for prostate cancer imaging. Aronen’s ability to bridge cutting-edge technology with clinical validation makes his work essential reading for radiologists, urologists, and researchers seeking to improve diagnostic precision and patient outcomes in oncology.
Research Focus
Key Achievements
Top Papers
- 1